WASHINGTON — Michelle McMurry-Heath, one of the most prominent faces of the drug industry in Washington, is on leave from her role as CEO of the Biotechnology Innovation Organization, the group confirmed on Sunday.
“The BIO CEO is currently on leave. BIO does not speculate on rumors relative to employees or personnel,” BIO Chief Public Affairs and Marketing Officer Rich Masters said.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
